Microsoft's 2029 quantum supercomputer ambitions may have hit a roadblock, as critics claim the company's 2025 quantum ...
Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results